FUNDAMENTALS · Fundamentals · India Healthcare

Sagility India (SAGILITY) Fundamentals 2026 — P/E 19.3x, Revenue Analysis | SniperIQ

Sagility India (SAGILITY) is a India-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ₹19,268 Crore, trading at ₹41.19 on the BSE. This SniperIQ fundamentals page covers Sagility India's valuation (P/E 19.3x, P/B 2.0x), profitability (net margin 13.0%), revenue (₹7,193 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₹19,268 Crore
P/E (TTM)19.3x
Net Margin13.0%
Revenue (FY26)₹7,193 Crore

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Sagility India's market cap?

Sagility India (SAGILITY) has a market capitalization of approximately ₹19,268 Crore, trading at ₹41.19 on the BSE. Market cap moves with the live share price.

What is Sagility India's P/E ratio?

Sagility India's trailing twelve-month P/E ratio is 19.3x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Sagility India?

Sagility India runs a net profit margin of 13.0%, a gross margin of 17.7%, and an operating margin of 17.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Sagility India generate?

Sagility India reported revenue of ₹7,193 Crore for fiscal year 2026, with net income of ₹925 Crore and earnings per share (EPS) of 1.98. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Sagility India pay a dividend?

Sagility India offers a trailing dividend yield of about 0.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Sagility India financially healthy?

Sagility India carries a debt-to-equity ratio of 0.11x and a current ratio of 1.55x, with a market beta of 0.33. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Sagility India a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sagility India (SAGILITY) the key facts are: market cap ₹19,268 Crore, P/E 19.3x, revenue ₹7,193 Crore, 52-week range 35.82-57.9. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Sagility India's full fundamentals live

Get Sagility India's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Sawai Group Holdings (4887) fundamentals · Onesource Specialty Pharma (ONESOURCE) fundamentals · Thermo Fisher Scientific (TMO) fundamentals · Caplin Point Laboratories (CAPLIPOINT) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons